Viewing Study NCT01323257

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-05-10 @ 7:27 PM
Study NCT ID: NCT01323257
Status: COMPLETED
Last Update Posted: 2012-10-11
First Post: 2011-03-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TMC435-TiDP16-C115 View
None TMC435-C115 View
None TMC435 View
None HCV View
None Hepatitis C View
None Hep C View
None healthy volunteers View